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Abstract: Dialysis is a life saving procedure and recommended way of treatment 
for end stage kidney diseases. Transplantation can also be useful source but it is 
restricted by financial limitations especially in developing countries like 
Pakistan. A little work has been done in literature regarding the estimated 
survival time of dialysis patients in Pakistan. So, this study has estimated the 
median survival time of male/females patients separately by parametric and non-
parametric approaches. Moreover, comparison of survival time to patients (≤ 50 
years and >50 years) was also compared. As censoring is an important part of 
the survival data which causes insensitivity to the usual procedures of analysis.  
Frequently, in modeling the survival data, most of the time we have no prior 
information about the theoretical distribution of survival time, that’s why, non-
parametric methods are commonly used. The significance of this study is the 
fitting of probability distribution of real life time data of dialysis patients which is 
not done before. It is very laborious job to fit an appropriate distribution of the 
data and estimation of parameters. We find that the probability distribution of 
our real life time data is weibull distribution.  
Finding suggested that the Kaplan-Meier method and weibull model based on 
Anderson-Darling test provided a very close estimate of the survival function in 
both genders and age groups. On the average survival time in males is relatively 
high but not statistically different from females. 
 
Keywords: Survival data, dialysis, parametric tests, non-parametric tests, Weibull 
distribution, Kaplan-Meier method. 
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1. Introduction 
 
The Chronic Kidney Disease (CKD) becomes a common disorder and there are growing burden 
of CKD patients with worldwide increasing prevalence. As documented by [6-8, 12] the high 
prevalence of CKD is confirmed by European, Australian and Asian studies.	  Hence it is obvious 
that globally there are a large number of patients with Chronic Kidney Disease (CKD). In 
America alone about 370,000 people undergo dialysis and among these around 50,000 people die 
each year due to kidney failure [3]. Many of the studies shown that one out of ten people, slightly 
or seriously, suffering any kind of kidney disease [4]. It has been revealed that out of every three 
Pakistani’s; one is suffering from kidney disease [13]. High prevalence of CKD and the high cost 
of Renal Replacement Therapy (RRT) are connected with end stage renal disease (ESRD). 
Dialysis is still the most common treatment of CKD, due to insufficient kidney donation to meet 
the requirements for renal transplantation. So it is apparent that CKD is a vital public health 
problem world widely. Particularly in Pakistan due to the high prevalence rate of Diabetes and 
Hypertension which are the major risk factors of CKD, Chronic Kidney disease is becoming a 
critical issue [13]. The increasing number of patients who have kidney disease and need dialysis 
is a sign of importance of research in the field of nephrology. Dialysis is in itself an invasive 
technique with its own setup of complications and morbidity/mortality. Up till now, physicians 
have done few descriptive researches related to causes of Kidney failure and quality of life of 
Dialysis patients, but there is rare chance of any documented statistical inferential work about 
survival of these patients, done by statisticians in Pakistan.  
Pakistan is an under-developed country and chronic renal failure has emerged as a crucial 
medical, social and economic problem for the people suffering from this disease. Caused by 
unawareness of common people or else poor symptomatic medical practice, chronic kidney 
disease developed to ESRD and patients have to experience the costly renal replacement therapy. 
Therefore, it’s very difficult for the people and government as well to afford all the expenses of 
dialysis modality. In Pakistan, cost of dialysis is eight times the average annual per capita 
income i.e. almost $3000 per year. Hemodialysis was introduced in Pakistan in 1970 and Eighty 
five percent patients maintained on hemodialysis [32]. Currently 175 hemodialysis centers are in 
running condition in Pakistan. These dialysis centers are positioned in four provinces of the 
country and more than hundred centers are located in Sindh and Punjab province’s major cities. 
The Dialysis registry of Pakistan (2008) reported 6351 patients in 175 Centers are being dialyzed 
in Pakistan [23]. 
Analysis of the data that measures lifetime or the length of time until the occurrence of the event, 
generally focuses on estimating the probability about individual who will survive for a given 
length of time. Several approaches have been proposed in the literature for analyzing the survival 
data analysis [19, 20].The nonparametric technique, Kaplan-Meier Product Limit Method 
(Kaplan-Meier, 1958) is applied to estimate the survival functions and hazard rates of the 
survival data [14]. In biomedicine, prior knowledge about the distribution of survival function is 
rarely available to enable an accurate hypothesis. Thus, nonparametric method is more 
appropriate to compare the survival functions in such situations. The Log-Rank Test proposed by 
Mantel (1966) is one of the tests available for comparison [22]. Several parametric methods of 
estimations are available to model survival data for which knowledge of the theoretical 
distribution ought to exist. 
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There are several theoretical distributions commonly considered for survival data, including 
Exponential, Generalized Gamma, Log Logistic and Weibull. Statistical tests are also available 
to compare two survival curves which follow the same distribution. For instance, Cox (1953) 
suggested an F-test for comparison of two exponential distributions without any restriction of 
censored observations [5]. To compare two survival times which follow Gamma distributions, 
Rao (1952) proposed a test which assumes that the ratio between the averages of both survival 
times follows F-distribution [26].  For uncensored survival times, Thoman, Bain and Antle 
(1969) and Thoman and Bain (1969) proposed a test by using maximum likelihood estimator 
[30, 29]. 
The main aim of this research is to study the survival curves of Dialysis Patients, by estimating 
and interpreting survivor functions from survival data by using the Kaplan-Meier estimates. And 
finally to fit an appropriate parametric model based on Anderson-Darling goodness of fit test. 
Survival time of Gender and patients greater than 50 years was also compared with less than 50 
years in order to observe any significant difference in survival time of both groups. 
 
 
2. Material and Methods 
 
“Survival analysis is concerned with statistical modals and methods for analyzing data, 
representing life times, waiting times or more generally times to the occurrence of some 
specified event. Outcome variable of interest is time until an event occurs. Such data denoted as 
survival data, can arise in various scientific fields including medicine, engineering, and 
demography” [17]. Moreover survival data can attain from laboratory studies of animals or from 
clinical studies of humans who experience acute diseases. Survival data can comprises on 
survival time, response given treatment, and patient distinctiveness, allied with response and 
survival [16]. 
 
2.1 Censoring or Censored Data 
A sample or observation is supposed to be censored, while by accident or design, the 
measurement of a random variable under study remains unobserved for several items in the 
sample. e.g., in a study, leukemia patients observed until they quit from state of the remission, if 
the period of study completed whereas the patient is still in remission (with no event) in that case 
the patient’s survival time is referred as censored. And in this situation the survival time of 
individual is equal to the follow up period of that individual. However if the patient quit from 
remission, later than the study bring to an end, the total survival time of patient can not be 
identified [16]. 
When time-related variables take on in research, for example survival and recurrence, the 
researchers do not know the results for all patients after the time of study is fulfilled, 
consequently these results are known as censored [9]. For those individuals who remain alive at 
the end of study or whose survival status was unidentified the Survival time can not be 
determined and this sort of observations are referred as censored observations. The individuals 
who remain alive at the end of study are called as withdrawn alive and whose status could not be 
evaluated because they moved away or refuse to become a part of experiment, described as lost 
to follow-up [10].  
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Patients do not usually commence treatment or come in the study simultaneously. When the 
entrance of patients in the study is not at the same time and numerous patients are remaining in 
the study after the period of follow up, the data is considered as progressively censored or doubly 
censored [9].When the end point of interest has not so far occur and personnel’s accurate 
survival time partially known at the right side of the follow-up period and study come to an end 
then this sort of data is known as Right-censored data. And the entire survival time which is 
incomplete, has been cut off (i.e. censored) from the right side [24]. 
Moreover, data may be left-censored. In left-censored data the survival time of a person is 
partially known at the left side of the follow-up period for that person. For instance, in a follow 
up study of HIV infection, if a person has already positive for the HIV virus before the start of 
follow-up duration, but the exact time of the first exposure to the virus is unknown. Since there is 
unidentified follow-up time from the time of primary exposure to the time of first positive HIV 
test, so the survival time is considered primarily censored on the left side [16]. 
The relevant data of the dialysis patients was acquired from Institute of Nephrology Sheikh Zaid 
Hospital Lahore, Pakistan. This hospital is a tertiary care centre and patients are referred not only 
from Punjab but also from other provinces of Pakistan. All sort of difficult and complicated cases 
are treated here. At the moment Components of Shaikh Zayed Medical Complex are Shaikh 
Zayed Hospital, Federal Postgraduate medical Institute, National health research Complex, 
Institute of Nursing and Health Sciences, Kidney Institute. Addition of the Institute of kidney 
Diseases as the 5th component of Shaikh Zayed Medical Complex is the Latest Achievement. 
Establishment of the Kidney Institute was approved in 1998. This is 220 beds faculty that will 
provide treatment to critically sick kidney patients including Kidney transplantation. The 
Institute will also provide opportunity for training of doctors at the Postgraduate level in the 
disciplines of Nephrology and Urology. 
The dataset consisted of a total of 138 patient records, including both censored (84 patients) and 
uncensored (54 patients) observations. Both gender categories were fairly well represented in 
this population as 67 of all patients were males and 71 females. These patients were followed at 
monthly basis for up to 36 months or to the date of death which ever was earlier. In medical 
researches we have no prior information about the distribution of data. Hence, in our study, we 
obtained survival and hazard curves for gender and age groups by using Product-Limit Method.  
It enabled us to estimate survival and hazard functions in the existence of censored cases.  
We performed our analysis into two steps and draw the conclusion after comparing the results. In 
the first step nonparametric technique, Product Limit Method is applied to estimate the survival 
functions and hazard rates and log rank test gives the statistical difference between the two 
survival functions. While in the second step, parametric approach starts with P-P Plot and the 
Anderson-Darling test to confirm the distribution of survival data. To find an appropriate 
distribution among the different available distributions is a painstaking job. After the immense 
effort it was found that the survival and hazard rates follow the Weibull Distribution in our data. 
The parameters of Weibull distribution are then estimated by Maximum Likelihood estimation 
method. Afterward survival functions are thus obtained by using the Weibull Distribution. 
Comparison of results from parametric and non-parametric tests suggested that the survival 
functions of Weibull Distribution and Product Limit Method supported the same conclusions. 
However, difference between the survival times of men and women were not statistically 
significant (at 5% level of significance), nor were the differences between patients in two age 
groups, ≤ 50 years and > 50 years. 
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2.2 Nonparametric approach 
The Survivor function S(t) gives the probability that a person survives longer than some 
specified time t: that is, S(t) gives the probability that the random variable T exceeds the 
specified time t. In practice Survivor function is estimated as: 
 
Number of individuals in the sample who survive longer than tˆ(t) = 
Total number of individuals in the sample
S    (1) 
 
Survivor or Survivorship function is non increasing function of time t, denoted by S(t), is defined 
as: 
 
S(t) = p(T ≥ t) = 1 - F(t)         (2) 
 
Moreover, KM estimator was also used to estimate the cumulative hazard function: 
 
hˆ(t) = −ln[sˆ(t)]           (3) 
 
The Hazard function denoted by h(t), also called the instantaneous failure rate, conditional 
mortality rate, force of mortality and age specific failure rate. Hazard function give the risk of 
failure per unit time during the aging process or instantaneous potential  per unit time for the 
event to occur, given that the individual has survived up to time t. It is defined as the probability 
of failure during a very small time interval i to i+1, assuming that the individual has survived 
until time i. In practice the hazard function is estimated as the proportion of patients dying in an 
interval per unit time, given that they have survived to the beginning of the interval: 
 
Number of patients dying per unit time in the intervalhˆ(t) = 
Number of patients surviving at t 
    (4) 
 
The hazard function can be expressed in terms of the cumulative distribution function F(t) and 
the probability density function f(t): 
 
f(t)h(t) = 
{1 - F(t)} 
          (5) 
 
The description of the diversity in two or more groups of the estimated survival time 
distributions and the plots of the survival rates are simply start of the survival analysis. Besides 
these descriptive guidelines, researchers require a statistical test to conclude that, these 
differences are statistically significant or caused by “chance variation”. As, a short dissimilarity 
perhaps statistically significant due to the large sample size and a large dissimilarity possibly will 
not, in the small sample size. So it is expected to execute a statistical test to calculate the amount 
of differences between two survival curves. The Log-Rank Test is used to compare the 
difference between the two survival curves.  
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2.3 Parametric Approach 
For choosing a basic survival distribution, simplest and efficient tool is graph which has long 
been used for display and interpretation of data. When data consists of censored and uncensored 
observations, then appropriate graphical technique is ‘Hazard Plotting’. Hazard Plotting’ is a 
subjective method based on visual examination in which observations are plotted against 
cumulative hazard values. To determine the appropriate probability distribution of the survival 
data amongst the available distributions we started with the graphical approach of P-P plot 
technique for modeling the hazard rates [18]. Subsequently, The Anderson-Darling Test 
(Stephens, 1974) is employed to test for Distributional Adequacy that a sample of data comes 
from a population with a specific distribution [28]. This is test which is more sensitive to 
deviations in the tails of the distribution and utilizes the specific distribution being tested, in 
computing critical values. 
 
H0: The data follows a specified distribution. 
Ha: The data do not follow a specified distribution.  
Test Statistic:  
 
Where: 
 
 
 
Where N is the sample size, F is the cumulative distribution function of specified distribution and 
Yi are the ordered data. For the Weibull distribution cumulative distribution function is:  
 
iF(y ) = 1 - [exp ( y) ]
γ− λ  
 
and λ, γ are scale and shape parameters respectively. 
 
2.4 The Weibull Distribution 
There are numerous commonly used survival distributions for instance, normal, log normal, 
exponential, weibull, gamma, logistic, extreme value type 1 distribution and fatigue life 
distribution. The entire distributions have been used extensively in recent years to deal with 
reliability of components, lifetimes, learning times, duration of epidemics, traveling times, 
material strengths, particle dimensions, radioactive intensities, rainfall amounts, and costs of 
industrial accidents. Weibull distribution is one of these lifetime distributions, named after the 
Swedish physicist Waloddi Weibull (1939) [32]. The weibull distribution with two parameters 
has hypothetical confirmations in technical as well as biomedical applications as a purely 
empirical model. Also it is a very flexible life distribution model and widely used parametric 
survival model for modeling failure times [11]. 
The Weibull distribution is defined as: 
The continuous random variable t has a weibull distribution, with parameters λ and γ if its 
density function is given by: 
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1f(t)= exp[ ( ) ] t  0,  > 0,  > 0t t γ ≥ λ γγ γ−γλ − λ       (6) 
 
And cumulative distributions function has the form: 
 
F(t)=1-[exp ( ) ]t γ− λ           (7) 
 
Survivorship function and Hazard function is, therefore: 
 
( ) exp[ ( ) ]S t t γ= − λ           (8) 
 
( ) ( )h t t γ−1= γλ λ           (9) 
 
Weibull distribution has two parameters, where γ is the shape parameter and λ is scale parameter. 
At γ <1, the failure rate decreases over time, at γ =1 failure rate remain constant over time, and at 
γ > 1 failure rate increases over time [18, 31]. 
 
2.4.1 Estimation of Parameters of fitted Distribution with Censored Observations 
Analytical procedures for estimating the most commonly used survival distributions are 
concerned with maximum likelihood estimates of the parameters of the exponential, Weibull, 
Lognormal, and Gamma distribution. In this study, we used the method of Maximum likelihood 
estimation to estimate parameters of the Weibull theoretical distribution. 
Density function of weibull distribution is: 
 
f (t) = γ γλ tγ-1 exp[-(λt)γ]    t ≥ 0, γ > 0, λ > 0       (10) 
 
Cohen (1965) and some other writers write the density function as: 
 
f (t) = γ
θ
 tγ-1 exp[-(  t
θ
γ
)]    t ≥ 0, γ > 0, θ > 0       (11) 
 
As θ in equation (11) is equal to 1 
γλ
. Estimation of λ and γ in equation (10) is equivalent to 
estimation of θ and γ in equation (11), and λ can be obtained from θ and γ. 
An experiment in which subjects are entered at different time and the experiment terminated 
after the fixed period of time. In this case the collected data is progressively censored data.  
The progressively censored ordered survival data are: 
 
t(1)  ≤  t(2)  ≤ . . . . . ≤ t( r) , t+(r+1), . . . . . . ,t+(n) 
 
If the survival distribution is Weibull with density of equation (11), the MLE of θ and γ can 
determined by solving the following two equations simultaneously. 
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r
γˆ
+ loge t(i )
i=1
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∑ −1 
θˆ
t(i )
γˆ loge t(i ) + t(i )
+ γˆ loge t(i )
+
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n
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r
∑
"
#
$
%
&
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ˆ ˆ
( ) ( )2
1 1
r 1 0ˆ ˆ
r n
i i
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t t
θ θ
γ +γ
= = +
⎡ ⎤
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∑ ∑         (13) 
By eliminating θˆ  between above two equations and simplifying we have: 
 
ˆ ˆ
( ) ( ) ( ) ( )
1 1
( )
ˆ ˆ 1
( ) ( )
1 1
log log
1 1 ˆ( ) log 0
ˆ
r n
i e i i e i r
i i r
e ir n
i
i i
i i r
t t t t
W t
rt t
γ +γ +
= = +
γ +γ =
= = +
+
γ = − − =
γ+
∑ ∑
∑
∑ ∑
    (14) 
 
These equations can be solved iteratively for the MLE of γˆ  by using the Newton-Raphson 
method. The Newton-Raphson method is a numerical iterative procedure that can be used to 
solve nonlinear equations [25, 1]. Iterative procedure is a technique of successive approximations 
and each approximation is called iteration. If the successive approximations approach the 
solution very closely than we say that iterations converge. 
Now an initial estimate of γ is required to solve equation (14) iteratively. If the initial estimate is 
close to the real value of γ than small number of iterations are needed. Cohen (1965) 
recommends a graphical method for initially estimating of γ, by using the fact that the coefficient 
of variation (CV) of the weibull distribution is a function of parameter γ [2]. The sample 
coefficient of variation is determined by: 
 
CV=  s
t
           (15) 
 
Where s and t  are the sample standard deviation and mean. CV can be plotted against different 
values of γ. By using sample coefficient of variation initial estimate of γ can be read from the 
graph. The obtained value should provide a satisfactory initial estimate for starting the iterative 
procedure for the MLE [18]. 
An initial estimate of γ for solving equation (14) iteratively can be obtained by considering all 
censored observations as exact. The sample coefficient of variation calculated by using all of the 
n observations, and value of γ can be read from the graph. 
Similarly after γˆ  determined, θˆ  can be estimated by: 
 
θˆ =
1
r
t(i )
γˆ + t(i )
+ γˆ
i=r+1
n
∑
i=1
r
∑
#
$
%
&
'
(           (16) 
 
Therefore λ in equation (10) may be estimated by: 
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λˆ = exp(−
loge θˆ
γˆ
) 	   	   	   	   	   	   	   	   	   	   (17) 
 
2.4.2 Comparison of two Theoretical Survival Functions 
For comparing two theoretical survival functions, following a particular model with their 
parameters, two tests can compare the distributions i.e. the likelihood ratio test and an F-test 
suggested by Cox (1952) .These two tests can test the hypothesis that, whether the two  
distributions are equal or not. These tests are also applicable for censored observations. Thoman 
and Bain (1969) proposed a test for uncensored samples, used for comparing two weibull 
distributions, with Maximum Likelihood Estimator [29]. To test the equality of two weibull 
distributions, the null and alternative hypotheses are: H0: γ1 = γ2 Vs.  H1: γ1 >γ2 
In case of rejection of null hypothesis, it is clear that the two weibull distributions are not come 
to similar. Conversely, if no proper evidence provided to reject the null hypothesis, then we also 
have to check the equality of two scale parameters λ1 and λ2, under the null and alternative 
hypothesis: H0: λ1 = λ2  against H1: λ1 < λ2  [18]. 
 
 
3. Results & Discussion 
 
The death rate (of 60.9%) among the dialysis patients was notable in this population. The 
survival rates by using the Kaplan-Meier estimates for males and females are given in Appendix 
as Table 1. Overall comparison of the males and females is done by using Kaplan-Meier 
estimates. For comparison in mean ages and survival time in both gender t-test for two 
independent samples was applied and results depicts no statistical differences as p-values were 
greater than 0.05. Mean survival time for males and females were noted as with ±SD 
(18.58±12.59; 16.01±11.66) respectively. Survival time is relatively high in case of males but not 
statistically different from females. Figure 1 presents the Survival Curves comparing male and 
female survival rates.  
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Figure 1. Survival Curves for Gender Group . 
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Table1. Survival and Hazard Rates by using Kaplan-Meier Method and Survival    Rates by using Weibull 
Distribution. 
Females Males 
Survival 
Time 
(months) 
Survival 
Rate 
K – M 
Hazard 
Rate 
K – M 
Survival 
Rate 
Weibull 
Survival 
Time 
(months) 
Survival 
Rate 
K – M 
Hazard 
Rate 
K – M 
Survival 
Rate 
Weibull 
1 0.9718 0.0285 0.9697 1 0.9701 0.0303 0.9684 
1 0.9718 0.0285 0.9697 1 0.9701 0.0303 0.9684 
2 0.9003 0.1049 0.9367 2 0.9403 0.0615 0.9384 
2 0.9003 0.1049 0.9367 2 0.9403 0.0615 0.9384 
2 0.9003 0.1049 0.9367 3 0.9104 0.0938 0.9096 
2   0.9003 0.1049 0.9367 3 0.9104 0.0938 0.9096 
2 0.9003 0.1049 0.9367 5 0.8497 0.1628 0.8551 
3 0.8860 0.1209 0.9032 5 0.8497 0.1628 0.8551 
5 0.8425 0.1713 0.8373 5 0.8497 0.1628 0.8551 
5 0.8425 0.1713 0.8373 5 0.8497 0.1628 0.8551 
5 0.8425 0.1713 0.8373 6 0.7890 0.2369 0.8292 
6 0.7538 0.2826 0.8053 6 0.7890 0.2369 0.8292 
6 0.7538 0.2826 0.8053 6 0.7890 0.2369 0.8292 
6 0.7538 0.2826 0.8053 6 0.7890 0.2369 0.8292 
6 0.7538 0.2826 0.8053 7 0.7732 0.2571 0.8042 
6 0.7538 0.2826 0.8053 8 0.7101 0.3422 0.7800 
6 0.7538 0.2826 0.8053 8 0.7101 0.3422 0.7800 
7 0.7236 0.3234 0.7740 8 0.7101 0.3422 0.7800 
7 0.7236 0.3234 0.7740 8 0.7101 0.3422 0.7800 
8 0.6633 0.4104 0.7435 9 0.6943 0.3647 0.7565 
8 0.6633 0.4104 0.7435 10 0.6312 0.4600 0.7338 
8 0.6633 0.4104 0.7435 10 0.6312 0.4600 0.7338 
8 0.6633 0.4104 0.7435 10 0.6312 0.4600 0.7338 
10 0.6482 0.4334 0.6853 10 0.6312 0.4600 0.7338 
11 0.6181 0.4810 0.6575 11 0.5996 0.5113 0.7118 
11 0.6181 0.4810 0.6575 11 0.5996 0.5113 0.7118 
13 0.5872 0.5323 0.6047 15 0.5830 0.5395 0.6305 
13 0.5872 0.5323 0.6047 16 0.5658 0.5693 0.6117 
14 0.5396 0.6169 0.5797 18 0.5481 0.6011 0.5758 
14 0.5396 0.6169 0.5797 19 0.5299 0.6350 0.5587 
14 0.5396 0.6169 0.5797 20 0.5116 0.6701 0.5422 
15 0.5048 0.6836 0.5555 22 0.4927 0.7078 0.5105 
15 0.5048 0.6836 0.5555 27 0.4729 0.7486 0.4393 
17 0.4525 0.7928 0.5097 28 0.4532 0.7912 0.4264 
17 0.4525 0.7928 0.5097 30 0.4306 0.8425 0.4016 
17 0.4525 0.7928 0.5097 31 0.4052 0.9031 0.3897 
21 0.4320 0.8393 0.4281 32 0.3799 0.3799 0.3783 
23 0.4114 0.8881 0.3919 35 0.3546 0.3546 0.3458 
24 0.3908 0.9394 0.3748     
25 0.3497 1.0506 0.3585     
25 0.3497 1.0506 0.3585     
27 0.3278 1.1151 0.3277     
28 0.3060 1.1841 0.3132     
32 0.2824 1.2642 0.2611      
Siddiqa, M. (2012). Electron. J. App. Stat. Anal., Vol. 5, Issue 2, 271 – 288. 
281 
Hazard function gives the risk of failure per unit time since the date of first dialysis. Graph of 
hazard function of two gender groups is given in Figure 2. 
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Figure 2. Hazard Curves of for Gender Group. 
 
Figure 1 shows that for about 13 months of the follow up, the probability of survival for 
members of both genders remains same but after that time, the survival time improves in males 
compared to females. Similarly, Figure 2 demonstrates that after passing the same months of 
disease, the hazard rate increases in females .Consequently, the widening gap between the both 
curves suggests that the survival of Males group improved later during follow-up than it is early 
on and risk of disease is elevated in females than males.   Overall, by Log-Rank test the P-value 
(0.223) indicates that the survival difference between two gender groups is not statistically 
significant. 
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Figure 3. Weibull P-P Plot for Females / Males. 
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The P-P plot indicates that the hazard rates of males and females follow the Weibull distribution. 
Weibull P-P Plot of Females and Males are presented in Figure 3. The Weibull P-P Plot of 
Hazard Functions for both gender categories showed linearity and seemed a better fit as 
compared to other distributions. The P-Values for Anderson-Darling test are greater than 0.05 for 
both gender categories, indicating that the survival functions follow the Weibull Distribution.  
The scale and shape parameters of Weibull distribution are estimated by the method of 
Maximum Likelihood. 
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Figure 4. Survival Curves of Kaplan-Meier and Weibull for Females/Males. 
 
For the Females group these values are γ1 = 1.09 and λ1 =0.040. For the Males group these values 
are γ2 =0.984 and λ2 = 0.030. Figure 4 graphically display the estimated survival distribution of 
Kaplan-Meier compared with Weibull distribution. Figure supports the claim that a Weibull 
distribution is an effective description to model the data of concern to our study. 
The Figure 4 shows that the median survival time for females when calculated from Kaplan-
Meier is 17 months and from Weibull curve, it is 36 months.  
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Figure 5. Comparison of Survival Functions of Theoretical Distribution for Gender Group. 
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In contrast, the median survival time for males, when calculated from Kaplan-Meier is 22 
months and from Weibull it is 32 months. Graphical comparison of survival functions for Gender 
groups calculated by theoretical distribution is shown in Figure 5. 
For testing the equality of two Weibull distributions f1(t) and f2(t), respectively for Males and 
Females,  the null and alternative hypotheses are: 
 
H0: γ1 = γ2  
H1: γ1 > γ2.  
 
The test statistic is 21 ˆ/ˆ γγ  = 1.1122, which is insignificant at the 0.05 level (ι0.05 = 1.332 for n= 
42). It provided no support to null hypothesis. Therefore, we had to check the equality of two 
scale parameters λ1 and λ2, under the hypothesis: H0: λ1 = λ2 against H1: λ1 < λ2. The decision rule 
is to reject H0 if,  
 
ˆ ˆ ˆ ˆ(log log )e eG Z1 2 2 1 α
γ + γ
= λ − λ >
2
 
 
Where G = -0.2983, which is also insignificant at the 0.05 level (ι0.05 = 0.394 for n= 42). 
 
3.1 Analysis for comparing Age groups 
Now the same procedure is repeated for age groups (≤50 & >50) to see if significant differences 
exist between these groups. The survival rates by using the Kaplan-Meier estimates for the age 
groups “less than or equal to 50” and “greater than 50” are given in the Appendix as Table 
2[TABLE 2 HERE]. The cutoff point for dividing the patients into two age groups was taken as 50 
years because the average age of the patients was 50 years. The Survival Curves of both Age 
groups, using Kaplan-Meier estimates are given in Figure 6. 
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Figure 6. Survival Curves of Patients of Age Groups. 
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Table 2. Survival Rates by Kaplan-Meier Method and Survival Rates by using Weibull Distribution for Age 
Groups -50. 
Age Group -Less than 50 Age Group -Greater than 50 
Survival 
Time 
(months) 
Survival 
Rate 
K – M 
Hazard 
Rate 
K – M 
Survival 
Rate 
Weibull 
Survival 
Time 
(months) 
Survival 
Rate 
K – M 
Hazard 
Rate 
K – M 
Survival 
Rate 
Weibull 
2 0.9481 0.0534 0.9525 1 0.9333 0.0690 0.9555 
2 0.9481 0.0534 0.9525 1 0.9333 0.0690 0.9555 
2 0.9481 0.0811 0.9525 1 0.9333 0.1241 0.9555 
2 0.9481 0.1249 0.9525 1 0.9333 0.1241 0.9555 
3 0.9221 0.1875 0.9262 2 0.8833 0.1241 0.9159 
3 0.9221 0.2045 0.9262 2 0.8833 0.2248 0.9159 
5 0.8826 0.3137 0.8731 2 0.8833 0.2248 0.9159 
5 0.8826 0.3137 0.8731 3 0.8667 0.3614 0.8788 
5 0.8826 0.3137 0.8731 5 0.7987 0.3614 0.8106 
6 0.8291 0.4148 0.8467 5 0.7987 0.3614 0.8106 
6 0.8291 0.4808 0.8467 5 0.7987 0.3614 0.8106 
6 0.8291 0.5531 0.8467 5 0.7987 0.3614 0.8106 
6 0.8291 0.5531 0.8467 6 0.6967 0.4114 0.779 
7 0.815 0.5531 0.8206 6 0.6967 0.4640 0.779 
8 0.7307 0.5791 0.7949 6 0.6967 0.5196 0.779 
8 0.7307 0.6347 0.7949 6 0.6967 0.5802 0.779 
8 0.7307 0.7714 0.7949 6 0.6967 0.5802 0.779 
8 0.7307 0.8106 0.7949 6 0.6967 0.6543 0.779 
8 0.7307 0.8977 0.7949 7 0.6627 0.7344 0.7489 
8 0.7307 0.8977 0.7949 7 0.6627 0.7344 0.7489 
9 0.7167 1.0620 0.7696 8 0.6288 0.8297 0.7202 
10 0.6604 1.1265 0.7448 8 0.6288 0.9409 0.7202 
10 0.6604 0.0534 0.7448 10 0.6118 1.0015 0.6664 
10 0.6604 0.0534 0.7448 11 0.5948 1.2639 0.6412 
10 0.6604 0.0811 0.7448 13 0.5598 0.0690 0.594 
11 0.6183 0.1249 0.7205 13 0.5598 0.0690 0.594 
11 0.6183 0.1249 0.7205 15 0.5198 0.1431 0.5506 
11 0.6183 0.3137 0.7205 15 0.5198 0.2248 0.5506 
14 0.5752 0.3137 0.6509 17 0.4798 0.2248 0.5106 
14 0.5752 0.3137 0.6509 17 0.4798 0.3614 0.5106 
14 0.5752 0.3332 0.6509 18 0.458 0.4114 0.4918 
15 0.5604 0.4148 0.6288 21 0.4362 0.4640 0.4396 
16 0.5453 0.4148 0.6074 27 0.3903 0.4914 0.3522 
17 0.5301 0.4148 0.5865 27 0.3903 0.6543 0.3522 
19 0.5145 0.4808 0.5464 28 0.3673 0.7809 0.3395 
20 0.4979 0.4808 0.5273 30 0.3391 0.9409 0.3155 
22 0.4801 0.6065 0.4906 31 0.3108 1.0816 0.3042 
23 0.4624 0.6645 0.4731 34 0.2826 1.1686 0.2727 
24 0.4446 0.6973 0.4562 35 0.2543 1.3692 0.2629 
25 0.4075 0.7337 0.4397         
25 0.4075 0.9442 0.4397         
28 0.389 0.1875 0.3935         
32 0.3458 0.1875 0.3386         
32 0.3458 0.1875 0.3386          
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The Log-Rank test was applied to check whether the hazard difference in two groups was 
significant. The P-value (0.382) indicates that the difference between two groups is insignificant. 
Our results indicate that the hazard rates of both age groups again followed the Weibull 
distribution. Weibull P-P Plot of Age group less than or equal to 50, and greater than 50 years are 
shown in Figure 7.  
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Figure 7. Weibull P-P Plot for Age Group (<= 50 and >50). 
 
The Weibull P-P Plot of Hazard Functions for both groups shows linearity and seems a better 
estimator as compared to other distributions. The P-value (0.200) for age group less than or equal 
to 50 years and the P-value (0.250) for age group greater than 50 years indicates that the survival 
functions follow the Weibull Distribution.  
The scale and shape parameters of Weibull distribution are estimated by the method of 
Maximum Likelihood estimation. For the Age group less than or equal to 50 years, these values 
are γ1 = 1.119 and λ1 = 0.033. For the Age Group-Greater than 50 years these values are γ2 = 
0.951 and λ2 = 0.038. Figure 8 displays the estimated survival distribution of Kaplan-Meier 
compare with Weibull distribution. 
From the figure 8 it is clear that the median survival time for age group less than 50 years 
calculated from Kaplan-Meier is 20 months and from Weibull it is 36 months. Also figure 8 
shows that the median survival time for age group greater than 50-years calculated from Kaplan-
Meier is 17 months and from Weibull is 29 months.  
To test the equality of two Weibull distributions f1(t) and f2(t), of both Age-50 groups,  it is 
adequate to test the hypotheses: H0: γ1 = γ2 Vs.  H1: γ1 > γ2. Test statistic is 211 ˆ/ˆ γγ  = 1.1766, 
which is insignificant at the 0.05 level ( ι0.05 = 1.332 for n= 42). So this provided no proper 
evidence to reject the null hypothesis, then have to check the equality of two scale parameters λ1 
and λ2, under the hypothesis: H0: λ1 = λ2 against H1: λ1 < λ2  and will reject H0 if,  
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ˆ ˆ ˆ ˆ(log log )e eG Z1 2 2 1 α
γ + γ
= λ − λ >
2
 
 
Where G = 0.1510, which is also insignificant at the 0.05 level (ι0.05= 0.394 for n= 42). 
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Figure 8. Survival Curves of Kaplan-Meier Method and Weibull for Age    Group- Less than 50 and greater 
than 50 years. 
 
People of this region become victim of ESRD at younger age because detection is not made in 
time and preventive measures are not adapted. The median age of ESRD population is calculated 
to be 44 years [27, 15]. Mostly people go to nephrologists late in the course of their disease.73% 
of patients consult nephrologists almost when they have developed ESRD [21]. Generally ESRD 
prevalent population opt the hemodialysis therapy and hemodialysis facilities are going better in 
numerous areas of the country. Still, the majority of patients expired or discontinues the therapy 
within the first three months due to economic limitations.   
In general cohort studies follow individuals for long period of time, which is time consuming and 
costly to perform. In this study three year time period to follow up Dialysis patients is carried 
out. A cohort of patients of single hospital with the same clinical conditions in a dialysis unit of 
ION- Sheikh Zayed hospital Lahore was taken out, and followed maintenance hemodialysis 
patients, to see how many patients experienced death. Results of almost same survival are arrived 
at, despite differentiation of age and gender due to limited time. As late-diagnosed dialysis 
treatment, infections and malnutrition are mostly causes of high mortality and leads to less 
survival chances of patients. Survival time is almost same in patients of different Age groups and 
Gender group provided that general health, nutritional status and quality of life of patients is not 
much fluctuate in this data set. 
For further study of greater than three years time periods and consulting more than one hospital, 
describing the individuals with different clinical conditions and different modalities are required 
for this population. Result from such a cohort study would have more accurately reflect the 
outcomes that would be seen in clinical practice, and long follow-up period might have resulted 
in more occurrences of events and reduced number of censored observations in the data. 
 
 
 
Siddiqa, M. (2012). Electron. J. App. Stat. Anal., Vol. 5, Issue 2, 271 – 288. 
287 
4.  Conclusion 
 
Survival functions for Males, Females Group, Age Group cut-of point at 50 were estimated by 
Kaplan-Meier estimates, and the equality of two survival functions in each group is tested by the 
Log-Rank test. The testing result suggests that each two survival functions are statistically 
insignificant at 5% level of significance. After selecting the theoretical Weibull Distribution we 
estimated the survival functions again. The Thoman and Bain test and Log rank test lead to same 
conclusions. The median survival time of both Gender and Age group are different for the 
current sample data but these results can not generalize to all the population. Overall it can be 
concluded that survival time of both gender and age (cut-off point at 50 years) are approximately 
identical. 
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